Michael Geffner
Directeur Technique/Scientifique/R&D chez IMMUNOVANT, INC.
Fortune : 4 M $ au 31/05/2024
Postes actifs de Michael Geffner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOVANT, INC. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Michael Geffner
Anciens postes connus de Michael Geffner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 28/01/2020 |
Formation de Michael Geffner
| Albany Medical College | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Bourse
- Insiders
- Michael Geffner
- Expérience
